Frequency of Circulating CD8+CD73+T Cells Is Associated With Survival in Nivolumab-Treated Melanoma Patients

Journal of Translational Medicine - United Kingdom
doi 10.1186/s12967-020-02285-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Presence of Circulating Her2-Reactive CD8 + T-Cells Is Associated With Lower Frequencies of Myeloid-Derived Suppressor Cells and Regulatory T Cells, and Better Survival in Older Breast Cancer Patients

Breast Cancer Research
Cancer ResearchOncology
2015English

Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy

JAMA Oncology
Cancer ResearchOncology
2019English

Circulating CD56bright NK Cells Inversely Correlate With Survival of Melanoma Patients

Scientific Reports
Multidisciplinary
2019English

P2.04-02 Predictive Value of Circulating Tumor Cells and Circulating Free DNA in NSCLC Patients Treated With Nivolumab

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Dramatic Survival Benefit With Nivolumab in Melanoma

Cancer Discovery
Oncology
2016English

Presence of Suppressor HIV-Specific CD8+ T Cells Is Associated With Increased PD-1 Expression on Effector CD8+ T Cells

Journal of Immunology
AllergyImmunology
2008English

Baseline Neutrophil-To-Lymphocyte Ratio (NLR) and Derived NLR Could Predict Overall Survival in Patients With Advanced Melanoma Treated With Nivolumab

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2018English

High Frequency of T Cells Specific for Cryptic Epitopes in Melanoma Patients

OncoImmunology
OncologyAllergyImmunology
2013English

Detection of Circulating Melanoma Cells in the Blood of Melanoma Patients

Melanoma Research
DermatologyCancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy